SGLT2 inhibitor-induced euglycaemic diabetic ketoacidosis may be due to abrupt, severe and transient impaired glucose sensing in susceptible individuals with a hitherto unrecognised beta cell SGLT variant-Reference-Cited by-同舟云学术

SGLT2 inhibitor-induced euglycaemic diabetic ketoacidosis may be due to abrupt, severe and transient impaired glucose sensing in susceptible individuals with a hitherto unrecognised beta cell SGLT variant

Published:2018-05 Issue: Volume:114 Page:11-12
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

Finucane F.M.

Publisher

Elsevier BV

Subject

General Medicine

Reference12 articles.

1. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N Engl J Med,2015

2. SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting System;Fadini;Diabetologia,2017

3. Perspective: SGLT2 inhibitors may predispose to ketoacidosis;Taylor;J Clin Endocrinol Metab,2015

4. Ketosis-prone type 2 diabetes: effect of hyperglycemia on beta-cell function and skeletal muscle insulin signaling;Umpierrez;Endocr Pract,2007

5. PANIC-ATTAC: a mouse model for inducible and reversible beta-cell ablation;Wang;Diabetes,2008

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium-Glucose Cotransporter 2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis: The Other Side of the Coin!;Cureus;2024-04-15

2. A Literature Review of the Therapeutic Perspectives of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis;Cureus;2022-09-27

3. Life-threatening complications for diabetic patients taking SGLT2 inhibitors when undergoing surgery: A poorly recognised problem?;Journal of Perioperative Practice;2022-03-15

4. Clinical and biochemical characteristics and analysis of risk factors for euglycaemic diabetic ketoacidosis in type 2 diabetic individuals treated with SGLT2 inhibitors: A review of 72 cases over a 4.5-year period;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2021-11

5. Sodium-glucose cotransporter-2-induced euglycemic diabetic ketoacidosis unmasks latent autoimmune diabetes in a patient misdiagnosed with type 2 diabetes mellitus: a case report;Journal of Medical Case Reports;2021-02-14